Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia

Authors
Category Primary study
Conference27th Congress of the European Sleep Research Society
Year 2024
This article has no abstract
Epistemonikos ID: 190be3a8ac71bcbcc8bcd8703447f5925e00be70
First added on: Jan 10, 2026